Skip to main content

Table 1 Characteristics of study participants (Nā€‰=ā€‰16,832)

From: Impact of smoking reduction on lung cancer risk in patients with COPD who smoked fewer thanĀ 30 pack-years: a nationwide population-based cohort study

Ā 

Sustainer

Reducer

Quitter

P-value

Nā€‰=ā€‰7,859

Nā€‰=ā€‰2,823

Nā€‰=ā€‰6,150

Age, years, mean (SD)

62.0 (10.6)

63.4 (11.0)

65.6 (10.5)

<ā€‰0.001

Sex (%)

Ā Ā Ā 

0.068

ā€ƒMale

6,876 (87.5)

2,428 (86.0)

5,393 (87.7)

Ā 

ā€ƒFemale

983 (12.5)

395 (14.0)

757 (12.3)

Ā 

Area, metropolitan (%)

4,515 (57.5)

1,606 (56.9)

3,454 (56.2)

0.312

Income (%)

Ā Ā Ā 

<ā€‰0.001

ā€ƒMedical Aid

571 (7.3)

211 (7.5)

301 (4.9)

Ā 

ā€ƒā‰¤ 30th

1,863 (23.7)

685 (24.3)

1,374 (22.3)

Ā 

ā€ƒ31st ā€“ 70th

2,763 (35.2)

977 (34.6)

2,138 (34.8)

Ā 

ā€ƒ> 70th

2,558 (32.5)

910 (32.2)

2,230 (36.3)

Ā 

ā€ƒUnknown

104 (1.3)

40 (1.4)

107 (1.7)

Ā 

BMI (%)

Ā Ā Ā 

<ā€‰0.001

ā€ƒUnderweight (<ā€‰18.5Ā kg/m2)

602 (7.7)

232 (8.2)

410 (6.7)

Ā 

ā€ƒNormal (18.5ā€“23Ā kg/m2)

3,142 (40.0)

1,184 (41.9)

2,290 (37.2)

Ā 

ā€ƒOverweight (23ā€“25Ā kg/m2)

1,778 (22.6)

591 (20.9)

1,444 (23.5)

Ā 

ā€ƒObesity (>ā€‰25Ā kg/m2)

2,337 (29.7)

816 (28.9)

2,005 (32.6)

Ā 

ā€ƒUnknown

0 (0.0)

0 (0.0)

1 (0.0)

Ā 

Drinking status (%)

Ā Ā Ā 

<ā€‰0.001

ā€ƒNo

3,268 (41.6)

1,284 (45.5)

3,314 (53.9)

Ā 

ā€ƒYes

4,588 (58.4)

1,538 (54.5)

2,834 (46.1)

Ā 

ā€ƒUnknown

3 (0.0)

1 (0.0)

2 (0.0)

Ā 

Regular physical activity (%)

1,000 (12.7)

405 (14.3)

907 (14.7)

0.002

Pack-year at Exam 1, mean (SD)

15.0 (7.3)

16.9 (6.8)

14.3 (7.6)

<ā€‰0.001

Daily smoking intensity at Exam 1 (%)

Ā Ā Ā 

<ā€‰0.001

ā€ƒLight

1,592 (20.3)

419 (14.8)

1,767 (28.7)

Ā 

ā€ƒModerate

4,515 (57.5)

1,541 (54.6)

3,421 (55.6)

Ā 

ā€ƒHeavy

1,752 (22.3)

863 (30.6)

962 (15.6)

Ā 

Medication*

Ā Ā Ā Ā 

ā€ƒICS (%)

711 (9.0)

299 (10.6)

689 (11.2)

<ā€‰0.001

ā€ƒLABA (%)

1,004 (12.8)

395 (14.0)

865 (14.1)

0.055

ā€ƒLAMA (%)

1,305 (16.6)

524 (18.6)

1,344 (21.9)

<ā€‰0.001

Severe exacerbation (%)*

479 (6.1)

215 (7.6)

665 (10.8)

<ā€‰0.001

Comorbidities*

Ā Ā Ā Ā 

ā€ƒCCI, mean (SD)

2.4 (2.2)

2.5 (2.3)

2.7 (2.4)

<ā€‰0.001

ā€ƒPulmonary tuberculosis (%)

175 (2.2)

82 (2.9)

185 (3.0)

0.01

ā€ƒInterstitial lung disease (%)

112 (1.4)

42 (1.5)

155 (2.5)

<ā€‰0.001

ā€ƒBronchiectasis (%)

208 (2.6)

78 (2.8)

272 (4.4)

<ā€‰0.001

ā€ƒPneumonia (%)

796 (10.1)

314 (11.1)

898 (14.6)

<ā€‰0.001

  1. BMI, body mass index; COPD, chronic obstructive pulmonary disease; CCI, Charlson comorbidities index; ICS, inhaled corticosteroid; LABA, long-acting beta-2 agonist; LAMA, long-acting muscarinic antagonist
  2. All variables were assessed at Exam 2, except for smoking pack-year and daily smoking intensity, which were assessed at Exam 1
  3. * These variables were assessed within 1 year of Exam 2